New and evolving treatment methods for pulmonary metastases

Seminars in Thoracic and Cardiovascular Surgery

Volumn 14, Issue 1, 2002, Pages 49-56

  Putnam Jr , Joe B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biological therapy; Chemotherapy; Inhalation; Lung perfusion; Metastasectomy

Indexed keywords

ACICLOVIR; ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; BIOLOGICAL RESPONSE MODIFIER; CAMPTOTHECIN DERIVATIVE; CARBOPLATIN; CHOLESTEROL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACARBAZINE; DOXORUBICIN; FLOXURIDINE; IFOSFAMIDE; INTERLEUKIN 2; LIPOSOME; MELPHALAN; METHOTREXATE; MURAMYL TRIPEPTIDE; OSTEOCALCIN; PLASMID DNA; PRODRUG; PROTAMINE SULFATE; PROTEIN P53; RUBITECAN; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT CHEMOTHERAPY; ARTICLE; BIOLOGICAL THERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; GENE THERAPY; HUMAN; LUNG METASTASIS; LUNG PERFUSION; LUNG RESECTION; LUNG TOXICITY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OCCULT CANCER; REGIONAL PERFUSION; SOFT TISSUE SARCOMA; TREATMENT PLANNING; VIRAL GENE DELIVERY SYSTEM;

EID: 0036250502     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/stcs.2002.32069     Document Type: Article

References (54)

1. Importance of the control of lung recurrence soon after surgery of pulmonary metastases
2. Secondary tumors of the lungs
3. Adriamycin: A new effective agent in the therapy of disseminated sarcomas
4. Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas
5. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: The M. D. Anderson Experience
6. Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases
7. The role of chemotherapy in the treatment of adult soft tissue sarcomas
8. Resection of pulmonary metastases in osteosarcoma. A retrospective analysis of 44 patients
9. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: Results from the multiinstitutional osteosarcoma study
10. Excision of pulmonary metastases of osteogenic sarcoma of the limbs
11. Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial
12. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: Treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide
13. Osteosarcoma of the extremities with synchronous lung metastases: Long-term results in 44 patients treated with neoadjuvant chemotherapy
14. Treatment of metastatic osteosarcoma at diagnosis: A Pediatric Oncology Group Study
15. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model
16. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection
17. Isolated single lung perfusion in the rat: An experimental model
18. Isolated lung perfusion for the treatment of pulmonary metastases an experimental study in the rat
19. Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma
20. Isolated lung perfusion with FUDR in the rat: Pharmacokinetics and survival
21. Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in rats
22. Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodule model
23. Isolated lung perfusion with antineoplastic agents for pulmonary metastases
24. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases
25. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma
26. Pulmonary toxicity of doxorubicin administered by in situ isolated lung perfusion in dogs
27. Pharmacokinetics of doxorubicin in isolated lung of dogs and humans perfused in vivo
28. Lung perfusion and other methods of targeting therapy to lung tumors
29. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas
30. Isolated lung perfusion for patients with unresectable metastases from sarcoma: A phase I trial
31. Rapid activation of MDRI gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin
32. Early results of isolated single lung perfusion for treatment of unresectable sarcomatous metastases
33. Specific organ gene transfer in vivo by regional organ perfusion with herpes viral amplicon vectors: Implications for local gene therapy
34. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide
35. Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma
36. A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies
37. 9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice
38. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice
39. Overview of interleukin-2 inhalation therapy
40. High dose inhalation interleukin-2 therapy for lung metastases in patients with malignant melanoma
41. MDM2 gene amplification in metastatic osteosarcoma
42. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control
43. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells
44. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas
45. Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases
46. Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases
47. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth
48. Inhibition of colon cancer metastasis by a 3′-end antisense urokinase receptor mRNA in a nude mouse model
49. In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy
50. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases
51. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung
52. Multidrug resistance and malignancy in human osteosarcoma
53. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma
54. Therapeutic implications of heat-induced lung injury. Matching the energy source to the clinical need: A critical review